Healthcare
204 companies · ₹2.6 L cr · 4 with AI deep dives
5y revenue CAGR
median 10.46%(p25 1% · p75 21.47%)
5y avg ROCE
median 11.05%(p25 4.07% · p75 18.62%)
Debt / equity
median 0.21x(p25 0.07x · p75 0.5x)
AI sector brief
from the bucket's latest earnings calls · as of 2026-03-31tailwindCDMO order momentum driving pharma manufacturing outperformance2 managements
Both pharma manufacturing companies in the bucket attributed their strongest-ever quarterly and annual revenues to CDMO execution. Anthem Biosciences' CRDMO segment grew 30.7% YoY…
- ANTHEM (Q4FY26): “This was our highest revenue quarter ever, that is in Q4 FY26. We delivered a revenue…”
4 more themes from this quarter's earnings calls are locked. A free account opens the full brief: every theme with verbatim management quotes, the demand picture, companies running against the tide, and the regulatory & disruption watch. Sign up free →
| Company | Mcap | AI verdict | Signals | Stated KPIs (latest call) |
|---|---|---|---|---|
| Abbott India Ltd | ₹55,960 cr | - | roce compounder | |
| Anthem Biosciences Ltd | ₹44,215 cr | 🔒 unlock to view | capex coming onlineroce compounderearnings quality strongnet cash | |
| Acutaas Chemicals Ltd | ₹25,760 cr | 🔒 unlock to view | capex coming onlinenet cashstory tensionpharma capex digesting | |
| Rubicon Research Ltd | ₹21,313 cr | - | roce compounder | |
| Park Medi World Ltd | ₹11,900 cr | 🔒 unlock to view | roce compounderearnings quality strong | |
| Corona Remedies Ltd | ₹10,603 cr | - | capex coming onlineroce compounderearnings quality strongpharma capex digesting | |
| Sudeep Pharma Ltd | ₹8,482 cr | - | capex coming onlineroce compounderearnings quality weakpharma capex digesting | |
| Jeena Sikho Lifecare Ltd | ₹7,669 cr | 🔒 unlock to view | roce compounderearnings quality strongnet cash | |
| Nephrocare Health Services Ltd | ₹7,450 cr | - | earnings quality strongnet cash | |
| Kovai Medical Center & Hospital Ltd | ₹6,325 cr | - | earnings quality strongcapex intensity elevated | |
| Gujarat Themis Biosyn Ltd | ₹4,250 cr | - | latent operating leveragecapex coming onlinemargin under pressureearnings quality strong | |
| Zota Health Care Ltd | ₹4,226 cr | - | latent operating leveragemargin under pressurenet cash | |
| Novartis India Ltd | ₹3,227 cr | - | story tension | |
| Kwality Pharmaceuticals Ltd | ₹2,583 cr | - | margin under pressure | |
| Sai Parenterals Ltd | ₹2,540 cr | - | capex coming onlineearnings quality strong | |
| Dr Agarwals Eye Hospital Ltd | ₹2,404 cr | - | latent operating leveragecapex coming onlineearnings quality strongcapex intensity elevated | |
| Fischer Medical Ventures Ltd | ₹2,362 cr | - | gross block efficient | |
| Kmc Speciality Hospitals India Ltd | ₹1,946 cr | - | latent operating leverageearnings quality strongstory tension | |
| Sakar Healthcare Ltd | ₹1,845 cr | - | earnings quality strongstory tension | |
| Beta Drugs Ltd | ₹1,795 cr | 🔒 unlock to view | ||
| Shukra Pharmaceuticals Ltd | ₹1,314 cr | - | capex coming onlineroce compounderearnings quality weaknet cash | |
| Fredun Pharmaceuticals Ltd | ₹1,268 cr | - | roce compounder | |
| One Global Service Provider Ltd | ₹1,239 cr | - | earnings quality weaknet cash | |
| 3B Blackbio DX Ltd | ₹1,064 cr | - | latent operating leveragemargin under pressurenet cashcapex intensity elevated | |
| Gujarat Kidney & Super Speciality Ltd | ₹1,033 cr | - | earnings quality weaknet cashcapex intensity elevated | |
| Fermenta Biotech Ltd | ₹979 cr | - | earnings quality strong | |
| Bharat Parenterals Ltd | ₹927 cr | - | latent operating leverage | |
| OSEL Devices Ltd | ₹819 cr | - | roce compounderearnings quality weakgross block efficient | |
| Remus Pharmaceuticals Ltd | ₹819 cr | - | capex coming onlineearnings quality weaknet cash | |
| Anlon Healthcare Ltd | ₹800 cr | - | earnings quality weak | |
| Anuh Pharma Ltd | ₹797 cr | - | ||
| Shree Ganesh Remedies Ltd | ₹770 cr | - | latent operating leverageearnings quality strongstory tension | |
| Unihealth Hospitals Ltd | ₹757 cr | - | earnings quality weakcapex intensity elevated | |
| Gaudium IVF and Women Health Ltd | ₹725 cr | - | capex coming onlineroce compounderearnings quality weakgross block efficient | |
| Fabtech Technologies Ltd | ₹656 cr | - | earnings quality weakgross block efficient | |
| Vasa Denticity Ltd | ₹647 cr | - | net cashgross block efficient | |
| Amanta Healthcare Ltd | ₹589 cr | - | capex coming onlineearnings quality strong | |
| Chandan Healthcare Ltd | ₹553 cr | - | roce compounderearnings quality weakcapex intensity elevatedgross block efficient | |
| Hemant Surgical Industries Ltd | ₹552 cr | - | earnings quality weak | |
| Influx Healthtech Ltd | ₹551 cr | - | roce compounderearnings quality weak | |
| Jenburkt Pharmaceuticals Ltd | ₹525 cr | - | latent operating leveragecapex coming onlineroce compoundercapex ahead of revenue | |
| KRM Ayurveda Ltd | ₹524 cr | - | roce compounderearnings quality weak | |
| Prevest Denpro Ltd | ₹461 cr | - | roce compoundernet cash | |
| Asarfi Hospital Ltd | ₹453 cr | - | earnings quality strong | |
| Aptus Pharma Ltd | ₹378 cr | - | roce compounderearnings quality weak | |
| Astal Laboratories Ltd | ₹336 cr | - | latent operating leveragenet cash | |
| Infinium Pharmachem Ltd | ₹298 cr | - | capex coming online | |
| Trident Lifeline Ltd | ₹298 cr | - | latent operating leveragecapex coming onlinelevering upstory tension | |
| Aprameya Engineering Ltd | ₹295 cr | - | earnings quality stronggross block efficient | |
| Zenotech Laboratories Ltd | ₹267 cr | - | earnings quality strong | |
| Gennex Laboratories Ltd | ₹255 cr | - | ||
| Sat Kartar Life Ltd | ₹255 cr | - | roce compounderearnings quality weaknet cash | |
| Everest Organics Ltd | ₹252 cr | - | capex coming onlineearnings quality strongdeleveragingcapex ahead of revenue | |
| Astonea Labs Ltd | ₹244 cr | - | earnings quality weak | |
| Ambalal Sarabhai Enterprises Ltd | ₹238 cr | - | earnings quality weak | |
| Bdh Industries Ltd | ₹235 cr | - | net cash | |
| Kerala Ayurveda Ltd | ₹224 cr | - | ||
| Hannah Joseph Hospital Ltd | ₹213 cr | - | earnings quality strong | |
| Syschem (India) Ltd | ₹208 cr | - | margin under pressurenet cash | |
| Vaidya Sane Ayurved Laboratories Ltd | ₹189 cr | - | net cashgross block efficient | |
| Accretion Nutraveda Ltd | ₹188 cr | - | earnings quality weak | |
| QMS Medical Allied Services Ltd | ₹185 cr | - | roce compounderearnings quality strongcapex intensity elevatedgross block efficient | |
| Sanjivani Paranteral Ltd | ₹182 cr | - | ||
| Oxygenta Pharmaceutical Ltd | ₹179 cr | - | ||
| Coral Laboratories Ltd | ₹179 cr | - | latent operating leveragenet cash | |
| Speciality Medicines Ltd | ₹178 cr | - | roce compounderearnings quality weaknet cash | |
| Aashka Hospitals Ltd | ₹176 cr | - | earnings quality weaknet cash | |
| Gujarat Inject (Kerala) Ltd | ₹174 cr | - | earnings quality strongstory tension | |
| Earkart Ltd | ₹172 cr | - | earnings quality weak | |
| Novelix Pharmaceuticals Ltd | ₹171 cr | - | capex coming onlinenet cash | |
| Quest Laboratories Ltd | ₹167 cr | - | roce compoundernet cash | |
| Abate As Industries Ltd | ₹162 cr | - | earnings quality weaknet cash | |
| Auro Laboratories Ltd | ₹162 cr | - | latent operating leverageearnings quality stronglevering upstory tension | |
| Natural Capsules Ltd | ₹160 cr | - | latent operating leveragemargin under pressureearnings quality strongdeleveraging | |
| Kimia Biosciences Ltd | ₹160 cr | - | deleveraging | |
| Jeevan Scientific Technology Ltd | ₹159 cr | - | margin under pressurecapital destroyerstory tension | |
| Achyut Healthcare Ltd | ₹155 cr | - | capex coming online | |
| Panchsheel Organic Ltd | ₹154 cr | - | latent operating leveragecapex coming onlinemargin under pressureearnings quality weak | |
| Accretion Pharmaceuticals Ltd | ₹152 cr | - | roce compounderearnings quality weak | |
| Star Imaging & Path Lab Ltd | ₹150 cr | - | roce compounderearnings quality strong | |
| Parnax Lab Ltd | ₹148 cr | - | net cashcyclical peak base | |
| Bilcare Ltd | ₹146 cr | - | margin under pressurecapital destroyercapex intensity elevated | |
| Lactose (India) Ltd | ₹137 cr | - | margin under pressureearnings quality strongdeleveraging | |
| Smruthi Organics Ltd | ₹132 cr | - | latent operating leverageearnings quality strong | |
| Tyche Industries Ltd | ₹128 cr | - | latent operating leveragemargin under pressure | |
| Balaxi Pharmaceuticals Ltd | ₹127 cr | - | latent operating leverage | |
| Aspira Pathlab & Diagnostics Ltd | ₹124 cr | - | earnings quality strong | |
| Sotac Pharmaceuticals Ltd | ₹123 cr | - | ||
| Ccme Global Ltd | ₹122 cr | - | ||
| Godavari Drugs Ltd | ₹122 cr | - | latent operating leveragecapex coming onlineearnings quality stronglevering up | |
| Nephro Care India Ltd | ₹115 cr | - | gross block efficient | |
| Par Drugs & Chemicals Ltd | ₹108 cr | - | earnings quality strong | |
| Maitreya Medicare Ltd | ₹102 cr | - | ||
| Pharmaids Pharmaceuticals Ltd | ₹102 cr | - | ||
| Denis Chem Lab Ltd | ₹101 cr | - | margin under pressureearnings quality strongnet cash | |
| Fortis Malar Hospitals Ltd | ₹99 cr | - | earnings quality weak | |
| Makers Laboratories Ltd | ₹94 cr | - | net cash | |
| Vaishali Pharma Ltd | ₹94 cr | - | ||
| Mercury Laboratories Ltd | ₹93 cr | - | capex coming onlineearnings quality strongcapex ahead of revenue | |
| Curis Lifesciences Ltd | ₹91 cr | - | roce compounderearnings quality weak |